2019
National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015
Chang TE, Ritchey MD, Park S, Chang A, Odom EC, Durthaler J, Jackson SL, Loustalot F. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015. Hypertension 2019, 74: 1324-1332. PMID: 31679429, DOI: 10.1161/hypertensionaha.119.13616.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAgedAged, 80 and overAntihypertensive AgentsCross-Sectional StudiesFemaleHumansHypertensionIncidenceInsurance Claim ReviewInsurance CoverageMaleMedicaidMedicare Part DMedication AdherenceMiddle AgedRetrospective StudiesRisk AssessmentSensitivity and SpecificitySex FactorsUnited StatesConceptsBlood pressure controlMedication nonadherence ratesAntihypertensive medicationsNonadherence ratesHypertensive adultsUS adultsHealth insurancePressure controlNational ratesAvailable evidence-based interventionsAntihypertensive medication regimenAntihypertensive medication therapyEstimates of nonadherenceInsurance plan typePrescription claims dataIBM MarketScan databasesProportion of daysMultiple administrative datasetsEvidence-based interventionsMedicare Part DMedication regimenMedication therapyMarketScan databaseGreater nonadherencePrivate health insurance
2018
A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017
Tong X, Wiltz JL, George MG, Odom EC, King S, Chang T, Yin X, team P, Merritt RK. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017. Circulation Cardiovascular Quality And Outcomes 2018, 11: e004981. PMID: 30557047, PMCID: PMC6329285, DOI: 10.1161/circoutcomes.118.004981.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, IntravenousAdolescentAdultAgedAged, 80 and overBrain IschemiaFemaleFibrinolytic AgentsHealthcare DisparitiesHumansMaleMiddle AgedQuality ImprovementQuality Indicators, Health CareRegistriesRisk AssessmentRisk FactorsStrokeThrombolytic TherapyTime FactorsTime-to-TreatmentTissue Plasminogen ActivatorTreatment OutcomeUnited StatesYoung AdultConceptsPaul Coverdell National Acute Stroke ProgramAcute ischemic stroke patientsAcute Stroke ProgramDTN timeIschemic stroke patientsStroke ProgramNeedle timeStroke patientsAcute ischemic stroke admissionsAcute ischemic strokeIschemic stroke admissionsEmergency medical servicesIntravenous alteplaseSevere strokeStroke admissionsIschemic strokeBlack patientsOutside hospitalClinical benefitMedical historyOdds ratioAlteplasePatientsStrokeMedical services